NeurOp Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NeurOp's estimated annual revenue is currently $1.1M per year.(i)
  • NeurOp's estimated revenue per employee is $155,000

Employee Data

  • NeurOp has 7 Employees.(i)
  • NeurOp grew their employee count by 0% last year.

NeurOp's People

NameTitleEmail/Phone
1
Chief Scientific OfficerReveal Email/Phone
2
HEAD, CORPORATE DEVELOPMENTReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$1.7M11-8%N/AN/A
#3
$2.3M1550%N/AN/A
#4
$1.1M70%N/AN/A
#5
$17.1M1105%$0.07BN/A
#6
$4M26-7%N/AN/A
#7
$0.8M50%N/AN/A
#8
$1.1M717%N/AN/A
#9
$7.8M502%N/AN/A
#10
$1.7M1110%N/AN/A
Add Company

What Is NeurOp?

NeurOp, Inc. is a clinical-stage, Atlanta-based biopharmaceutical company developing new medicines for central nervous system disorders, including severe pain, subarachnoid hemorrhage (SAH), and catastrophic juvenile epilepsies. Its technology targets the GluN2B subunit of neuronal NMDA receptors and its potential therapeutic benefit. Multi-year funding from the NIH supports NeurOp's research and development programs for NP10679, its drug candidate for the prevention of ischemic damage during a stroke or subarachnoid hemorrhage (SAH) and severe pain. For more information, please visit www.neuropinc.com

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M7N/AN/A
#2
$0.5M7N/AN/A
#3
$0.5M7N/AN/A
#4
$0.9M7N/AN/A
#5
$0.5M7N/AN/A